Direxion Daily Pharmaceutical & Medical Bull 3X Shares (NYSEARCA:PILL) Sees Significant Drop in Short Interest

Direxion Daily Pharmaceutical & Medical Bull 3X Shares (NYSEARCA:PILLGet Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totaling 75,375 shares, a drop of 31.0% from the November 30th total of 109,232 shares. Based on an average daily trading volume, of 138,678 shares, the days-to-cover ratio is presently 0.5 days. Currently, 5.6% of the shares of the stock are short sold. Currently, 5.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 138,678 shares, the days-to-cover ratio is presently 0.5 days.

Direxion Daily Pharmaceutical & Medical Bull 3X Shares Stock Performance

Shares of Direxion Daily Pharmaceutical & Medical Bull 3X Shares stock traded down $0.45 on Tuesday, reaching $12.48. 208,384 shares of the stock were exchanged, compared to its average volume of 97,702. The firm has a market cap of $16.85 million, a PE ratio of 10.33 and a beta of 1.78. The firm’s 50 day moving average is $10.61 and its 200-day moving average is $8.17. Direxion Daily Pharmaceutical & Medical Bull 3X Shares has a one year low of $3.62 and a one year high of $13.33.

About Direxion Daily Pharmaceutical & Medical Bull 3X Shares

(Get Free Report)

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is managed by Direxion.

Featured Stories

Receive News & Ratings for Direxion Daily Pharmaceutical & Medical Bull 3X Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily Pharmaceutical & Medical Bull 3X Shares and related companies with MarketBeat.com's FREE daily email newsletter.